Brief: Champions Biotechnology Q2 Revenue Up 28.6 Pct

Champions Oncology

17/12/2018 22:29

Dec 17 (Reuters) - Champions Biotechnology  Inc  CSBR.O :
    * Q2 REVENUE ROSE 28.6 PERCENT TO $6.7 MILLION
    * CHAMPIONS BIOTECHNOLOGY  INC QTRLY REVENUE OF $6.7
MILLION, UP
28.6%
    * CHAMPIONS BIOTECHNOLOGY  INC - REITERATED FORECAST OF AT
LEAST
20% REVENUE GROWTH IN FISCAL 2019 AND SUSTAINED, QUARTERLY
OPERATIONAL PROFITABILITY
    * CHAMPIONS BIOTECHNOLOGY  INC QTRLY GAAP EARNINGS PER SHARE
$0.02
    * CHAMPIONS BIOTECHNOLOGY  INC QTRLY EPS - NON-GAAP WAS
$0.03

Source text - https://bit.ly/2SSmAdJ
Further company coverage:  CSBR.O 

 ((Reuters.Briefs@thomsonreuters.com;))